In this week’s edition to “Ask Dr. J”, Dr. Jaffe is asked, “If your LRA test comes back reactive to a medication, do you recommend not taking it?”
In this week’s edition of “Ask Dr. J”, Dr. Russell Jaffe is asked about the antigen process when it relates to LRA by ELISA/ACT testing.
In this week’s edition of “Ask Dr. J”, Dr. Russell Jaffe is asked how does a teenager show lymphocyte responsive assay sensitivities to chemicals that have been banned in the United States for several years.
In this week’s “Ask Dr. J”, Dr. Russell Jaffe is asked to explain how certain medications can interfere with LRA tests.
ELISA/ACT Biotechnologies founder, Dr. Russell Jaffe, recently lectured on the topic of functional immunology to students of National University of Health Sciences. Joined by former NUHS faculty Dr. Erica Mennerik, the two presented the foundations and practical applications of functional immunology, including numerous case reports documenting success in removing obstacles to repair and evoking the healing response. Read more
Click here to read more about clinical success with LRA tests and treatment plan.
Clinical relevance of biological response modifiers in autoimmunity.
Diagnosis, treatment, tests and interpretation.
By Russell Jaffe, MD, Ph.D.,CCN
A common clinical assumption is that homeostatic mechanisms and immune defense and repair reserves are intact or can be spontaneously restored. This is not the case in autoimmune illnesses where homeostasis and immune defenses have been disrupted as marked by intracellular acidosis, impaired electron transport, and depletion of biochemical cofactors, often concurrently present. The cases and consequences for this are addressed in this article with emphasis on differential diagnosis and recent advances in laboratory testing. Read more
In this week’s “Ask Dr. J”, Dr. Russell Jaffe is asked “What does it mean when PERQUE Potent C Guard …